The Centre for Digestive Diseases (CDD) Department of Research and Innovation is a clinical research group, working often in conjunction with pharmaceutical or biotechnology companies to conduct clinical trials.
Clinical research is vital for the development of new products and treatments, as well as medical devices.
All clinical research conducted at the CDD is reviewed by a Human Research Ethics Committee (HREC). The HREC functions in accordance with the National Statement on Ethical Conduct in Research involving Humans as issued by the National Health and Medical Research Council (NHMRC) in accordance with the NHMRC Act, 2007 (Cth), ICH / TGA Good Clinical practice (GCP) guidelines (2000), and the Declaration of Helsinki (2004).
The CDD Department of Research and Innovation is contracted as a clinical research site for many international pharmaceutical sponsored studies in the field of gastroenterology.
The CDD is sought out by many large international Contract Research Organisation’s (CRO’s) to provide a highly professional and clinical standard of research.
Internal clinical studies designed and directed by Prof. Thomas Borody are conducted to develop treatments and provide new therapies based on his experience in clinical practice.
The CDD through its Department of Research and Innovation provides new and effective therapies to patients that would otherwise be unavailable to the wider community.